Active Pharmaceutical Ingredients
What Does Ecdysterone powder Do for the Body?
Ecdysterone powder have physiological activities in the human body, such as promoting protein synthesis, eliminating cholesterol, lowering blood lipids, and inhibiting blood sugar rise. It has been used clinically and in folk medicine for rheumatoid arthritis.
Concurrently, it decreases LDL cholesterol by 25% via hepatic LDL receptor upregulation.
Neuroprotection: In vitro studies show ecdysterone reduces β-amyloid-induced neuronal apoptosis by 40-60% through JNK and Akt signaling pathways, suggesting potential in neurodegenerative disease management.
Adaptogenic Properties: Exhibits stress-protective effects by stabilizing mitochondrial function under oxidative stress conditions, preserving ATP production efficiency by 35-50%.
Concurrently, it decreases LDL cholesterol by 25% via hepatic LDL receptor upregulation.
Neuroprotection: In vitro studies show ecdysterone reduces β-amyloid-induced neuronal apoptosis by 40-60% through JNK and Akt signaling pathways, suggesting potential in neurodegenerative disease management.
Adaptogenic Properties: Exhibits stress-protective effects by stabilizing mitochondrial function under oxidative stress conditions, preserving ATP production efficiency by 35-50%.
COA
| Analysis | Description | Test Method |
| Appearance | Light yellow to white Powder | Visual |
| Odor | Characteristic | Organoleptic |
| Identification | Conform with reference sample | Organoleptic |
| Mesh Size | 100% pass 80 mesh | 80mesh screen |
| Moisture Content | ≤ 1.0% | GB5009.3-2016 |
| Heavy Metals | ≤ 10 ppm | GB 5009.3 |
| Arsenic (As) | ≤ 1.5 ppm | GB 5009.4 |
| Lead (Pb) | ≤ 2 ppm | GB 5009.11 |
| Cadmium（Cd） | ≤1ppm | GB 5009.12 |
| Mercury （Hg） | ≤1ppm | GB 5009.17 |
| Total Plate Count | ≤10000 cfu/g | GB 5009.15 |
| Yeast and Mold | ≤100 cfu/g | GB 5009.3 |
| Escherichia Coli | < 10cfu/g | GB 5009.4 |
| Salmonella/25g | Absent | GB 5009.11 |
| Effective constituent | Ecdysterone≥98% | HPLC |
How Long Does Ecdysterone Take to Kick In?
Initial Effects: Ecdysterone bioactive metabolites appear in plasma within 30-45 minutes post-oral administration, correlating with acute glucose-lowering effects observed in rodent models.
Peak Anabolic Activity: Maximal muscle protein synthesis stimulation occurs at 4-6 hours, sustained for 12-18 hours per dose. This prolonged window enables once-daily dosing regimens.
Cumulative Benefits: Human intervention studies note measurable strength gains manifest after 2-3 weeks of consistent supplementation (typically 50-200mg/day), with peak efficacy at 8-10 weeks.
Peak Anabolic Activity: Maximal muscle protein synthesis stimulation occurs at 4-6 hours, sustained for 12-18 hours per dose. This prolonged window enables once-daily dosing regimens.
Cumulative Benefits: Human intervention studies note measurable strength gains manifest after 2-3 weeks of consistent supplementation (typically 50-200mg/day), with peak efficacy at 8-10 weeks.
Does Ecdysterone Affect the Liver?
Metabolic Support: In obese Zucker rats, 6-month ecdysterone supplementation (0.5g/kg diet) reduced hepatic triglyceride accumulation by 40% and improved ALT/AST ratios by 25%, indicating hepatoprotective potential.
Detoxification Enhancement: Upregulates phase II detox enzymes (e.g., glutathione S-transferase) by 2-3 fold, accelerating xenobiotic clearance without inducing cytochrome P450 isoforms linked to drug interactions.
Stress Mitigation: Prevents immobilization stress-induced mitochondrial uncoupling in rat liver, maintaining ATP synthesis efficiency at 85-90% of baseline levels.
Safety Profile: No histopathological abnormalities were observed in 90-day rodent studies at doses up to 100μg/day, suggesting wide therapeutic margins.
Detoxification Enhancement: Upregulates phase II detox enzymes (e.g., glutathione S-transferase) by 2-3 fold, accelerating xenobiotic clearance without inducing cytochrome P450 isoforms linked to drug interactions.
Stress Mitigation: Prevents immobilization stress-induced mitochondrial uncoupling in rat liver, maintaining ATP synthesis efficiency at 85-90% of baseline levels.
Safety Profile: No histopathological abnormalities were observed in 90-day rodent studies at doses up to 100μg/day, suggesting wide therapeutic margins.
Where to buy Ecdysterone powder?
Buy Ecdysterone powder - Contact SoST Biotech Factory for:
✓ Bulk discounts (MOQ 25kg)
✓ FREE 20g samples with COA
✓ OEM services/Specification Customization
Email:ericyang@xasost.com
Packing & Shipping
What We Can Do?
Product Data Sheets
| Analysis | Description | Test Method |
| Appearance | Light yellow to white Powder | Visual |
| Odor | Characteristic | Organoleptic |
| Identification | Conform with reference sample | Organoleptic |
| Mesh Size | 100% pass 80 mesh | 80mesh screen |
| Moisture Content | ≤ 1.0% | GB5009.3-2016 |
| Heavy Metals | ≤ 10 ppm | GB 5009.3 |
| Arsenic (As) | ≤ 1.5 ppm | GB 5009.4 |
| Lead (Pb) | ≤ 2 ppm | GB 5009.11 |
| Cadmium（Cd） | ≤1ppm | GB 5009.12 |
| Mercury （Hg） | ≤1ppm | GB 5009.17 |
| Total Plate Count | ≤10000 cfu/g | GB 5009.15 |
| Yeast and Mold | ≤100 cfu/g | GB 5009.3 |
| Escherichia Coli | < 10cfu/g | GB 5009.4 |
| Salmonella/25g | Absent | GB 5009.11 |
| Effective constituent | Ecdysterone≥98% | HPLC |
| Analysis | Description | Test Method |
| Appearance | Light yellow to white Powder | Visual |
| Odor | Characteristic | Organoleptic |
| Identification | Conform with reference sample | Organoleptic |
| Mesh Size | 100% pass 80 mesh | 80mesh screen |
| Moisture Content | ≤ 1.0% | GB5009.3-2016 |
| Heavy Metals | ≤ 10 ppm | GB 5009.3 |
| Arsenic (As) | ≤ 1.5 ppm | GB 5009.4 |
| Lead (Pb) | ≤ 2 ppm | GB 5009.11 |
| Cadmium（Cd） | ≤1ppm | GB 5009.12 |
| Mercury （Hg） | ≤1ppm | GB 5009.17 |
| Total Plate Count | ≤10000 cfu/g | GB 5009.15 |
| Yeast and Mold | ≤100 cfu/g | GB 5009.3 |
| Escherichia Coli | < 10cfu/g | GB 5009.4 |
| Salmonella/25g | Absent | GB 5009.11 |
| Effective constituent | Ecdysterone≥98% | HPLC |